58966-34-0

Basic information

• Product Name: 5-Chloro-2-methylbenzaldehyde
• Synonyms: 5-Chloro-2-methylbenzaldehyde;3-Chloro-6-methylbenzaldehyde
• CAS NO: 58966-34-0
• Molecular Formula: C₈H₇ClO
• Molecular Weight: 154.59358
• Mol File: 58966-34-0.mol

Chemical Properties

• Boiling Point: 233℃
• Flash Point: 105℃
• Appearance: /
• Density: 1.195
• Vapor Pressure: 0.0581mmHg at 25°C
• Refractive Index: 1.562
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 5-Chloro-2-methylbenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Chloro-2-methylbenzaldehyde(58966-34-0)
• EPA Substance Registry System: 5-Chloro-2-methylbenzaldehyde(58966-34-0)

Safety Data

• Hazardous Substances Data: 58966-34-0(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
5-Chloro-2-methylbenzaldehyde is used as a key intermediate in the synthesis of various other chemicals, contributing to the development of new compounds with potential applications in different industries.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, 5-Chloro-2-methylbenzaldehyde is utilized as a building block for the creation of new drug molecules, potentially leading to the discovery of novel therapeutic agents.
Used in Agrochemical Industry:
5-Chloro-2-methylbenzaldehyde is employed as a starting material in the production of agrochemicals, such as pesticides and herbicides, aiming to improve agricultural productivity and crop protection.
Used in Dye and Pigment Industry:
This chemical compound is used as a precursor in the synthesis of dyes and pigments, which are essential for coloring textiles, plastics, and other materials in various industries.
Used in Flavor and Fragrance Industry:
5-Chloro-2-methylbenzaldehyde is utilized in the formulation of fragrances and flavors, adding unique scents and tastes to consumer products, such as perfumes, cosmetics, and food items.

InChI:InChI=1/C8H7ClO/c1-6-2-3-8(9)4-7(6)5-10/h2-5H,1H3

Upstream product

• 39087-23-5 (4-Chloro-benzyl)-dimethyl-phenylsulfanylmethyl-ammonium; chloride 
• 104-83-6 1-Chloro-4-(chloromethyl)benzene 
• 4885-02-3 Dichloromethyl methyl ether 
• 106-43-4 para-chlorotoluene 
• 2591-86-8 N-Formylpiperidine 
• 27139-97-5 2-bromo-4-chloro-1-methyl-benzene 
• 75-17-2 formaldoxime 
• 615-65-6 2-chloro-4-methyl-benzenamine 
• 68-12-2 N,N-dimethyl-formamide 
• 33184-48-4 4-chloro-2-iodotoluene 
• 611-74-5 N,N-dimethylbenzamide 

Downstream Products

• 58966-29-3 (5-chloro-2-methylphenyl)methanol 
• 90797-94-7 5-Chlor-2-methyl-zimtsaeure 
• 1001332-45-1 1-(5-chloro-2-methyl-phenyl)-3-trimethylsilyloxy-2-aza-1,3-butadiene 
• 1352802-92-6 5-chloro-2-methylbenzaldehyde tert-butylimine 
• 1352803-33-8 7-chloro-1-fluoro-3-(3-fluorophenyl)isoquinoline 
• 1352803-34-9 N-tert-butyl-7-chloro-3-(3-fluorophenyl) isoquinolin-1-amine 
• 1093865-27-0 ethyl 3-[(5-chloro-2-methylphenyl)(hydroxy)methyl]benzoate 
• 239132-34-4 4-(5-chloro-2-methylphenyl)-3-buten-2-one 
• 58630-80-1 7-chloro-4-methyl-indan-1-one 
• 900027-20-5 5-Chlor-2-methyl-hydrozimtsaeure 
• 58966-30-6 Ethyl-2-methyl-5-chlorbenzylsulfon 
• 58966-21-5 Ethyl-2-methyl-5-chlorbenzylsulfid 
• 869721-21-1 5-chloro-2-methyl-benzyl bromide 
• 1093865-93-0 C₁₉H₂₀ClIO₃ 

Relevant articles and documents

Large-steric-hindrance triarylmethane derivative and synthesis method thereof

The invention provides a large-steric-hindrance triarylmethane derivative which has a general formula as shown in a compound (1) which is described in the specification. In the general formula, R1 isa C1-C6 alkyl group or C1-C6 alkoxy group; R2 is a C1-C6 alkyl group or C1-C6 alkoxy group; R3 is a C1-C6 alkyl group; R4 is independently selected from hydrogen, a methyl group, a methoxy group, halogen, a halogen substituted methyl group, a phenyl group and a naphthyl group; R5 is independently selected from hydrogen, a methyl group, a methoxy group, halogen, a halogen substituted methyl group,a phenyl group and a naphthyl group; R6 is respectively independent hydrogen, a methyl group, a methoxy group, halogen, a halogen substituted methyl group, a phenyl group and a naphthyl group; and X is halogen. The method has the advantages of simple operation, cheap and easily available raw materials, and suitableness for mass production.

SUBSTITUTED PYRROLES ACTIVE AS KINASES INHIBITORS

The present invention relates to substituted pyrrole compounds which modulate the activity of protein kinases and are therefore useful in treating diseases caused by dysregulated protein kinase activity, in particular Jak family kinases. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing such compounds or the pharmaceutical compositions containing them.

Secondary Amines as Renin Inhibitors

The invention relates to novel secondary amine derivatives of formula (I) and the use thereof as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.

Spiroindolinone Derivatives

There are provided compounds of the formula and pharmaceutically acceptable salts and esters and enantiomers thereof wherein W, X, X′, Y, V, V′, A, B and R are as described herein. The compounds have utility as antiproliferative agents, especially, as anticancer agents.

SECONDARY AMINES AS RENIN INHIBITORS

The invention relates to novel secondary amine derivatives of formula (I) and the use thereof as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.

Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof

The present invention is to provide a compound of the formula: wherein the ring A is an optionally substituted 5- to 6-membered aromatic heterocyclic ring, the ring B an optionally substituted 5- to 6-membered aromatic homocyclic ring or an optionally sub

Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment

Compounds of formula I: as well as pharmaceutically acceptable salts, hydrates and esters thereof, are disclosed. The compounds are useful for treating or preventing prostaglandin mediated diseases. Pharmaceutical compositions containing such compounds and methods of treatment are also included.